Sign In
Buy APLT
$0.0959
+0 (+0%)
At Close: Apr 28, 2026
BOSTON, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, is investigating whether Applied Therapeutics, Inc. (NASDAQ: APLT) and cert
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
09:29pm, Tuesday, 18'th Aug 2020
Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("GTT" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Robert S. Willoughby at newact
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Applied Therapeutics, Inc. (APLT) Investigation
03:10pm, Tuesday, 18'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 18, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc.
New Strong Sell Stocks for August 17th
01:14pm, Monday, 17'th Aug 2020
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Applied Therapeutics Reports Second Quarter 2020 Financial Results
11:00am, Tuesday, 11'th Aug 2020
NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molec
Terns Pharmaceuticals Appoints Senthil Sundaram as CEO, Mark Vignola, Ph.D., as CFO, and Erin Quirk, M.D., as President.
Applied Therapeutics Inc. (APLT) Gains But Lags Market: What You Should Know
09:45pm, Monday, 03'rd Aug 2020
In the latest trading session, Applied Therapeutics Inc. (APLT) closed at $25.93, marking a +0.5% move from the previous day.
Applied Therapeutics Inc. (APLT) Outpaces Stock Market Gains: What You Should Know
09:50pm, Monday, 27'th Jul 2020
Applied Therapeutics Inc. (APLT) closed the most recent trading day at $25.74, moving +1.74% from the previous trading session.
What to Expect for Applied Therapeutics (APLT) Q2 Earnings
04:58pm, Thursday, 23'rd Jul 2020
During Applied Therapeutics' (APLT) upcoming Q2 earnings call, investor focus will be on the company's progress with its novel pipeline candidates targeting areas of high unmet medical need.
Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services
01:25pm, Tuesday, 21'st Jul 2020
Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services
NEW YORK, July 17, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against.
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
03:30pm, Friday, 10'th Jul 2020
Is (APLT) Outperforming Other Medical Stocks This Year?
What Type Of Shareholders Own The Most Number of Applied Therapeutics, Inc. (NASDAQ:APLT) Shares?
01:05pm, Friday, 10'th Jul 2020
If you want to know who really controls Applied Therapeutics, Inc. (NASDAQ:APLT), then you'll have to look at the...
Vaccinex (VCNX) Catches Eye: Stock Jumps 8.1%
12:37pm, Tuesday, 07'th Jul 2020
Vaccinex (VCNX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Short Interest in Applied Therapeutics (NASDAQ:APLT) Increases By 11.7%
03:16am, Tuesday, 07'th Jul 2020
Applied Therapeutics (NASDAQ:APLT) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 802,800 shares, a growth of 11.7%
